Wiley Matthew T.
SEC CIK 1759703 · EDGAR
BoughtSold
Most active insiders at DFTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barrow Robert | CEO, Dir | — | $3.08M |
| 2 | Sullivan Mark | CLO | — | $1.04M |
| 3 | Karlin Daniel | Chief Medical Off | — | $748.9K |
| 4 | Roberts Brandi | CFO | — | $135.7K |
| 5 | Wiley Matthew T. | Chief Commercial Off | — | $129.1K |
| 6 | Adsett Roger | Dir | — | — |
| 7 | CRYSTAL ROGER | Dir | — | — |
| 8 | Bruhn Suzanne Louise | Dir | — | — |
| 9 | Krebs Andreas | Dir | — | — |
| 10 | Vallone Carol A | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 08:30 | 2026-09-14 | DFTX | Definium Therapeutics, Inc. | Wiley Matthew T. | Chief Commercial Off | A - Grant | $0.00 | +125.0K | 362.1K | +53% | $0 | |
| 2026-08-12 08:30 | 2026-08-12 | DFTX | Definium Therapeutics, Inc. | Wiley Matthew T. | Chief Commercial Off | A - Grant | $0.00 | +62.5K | 237.1K | +36% | $0 | |
| T | 2026-06-26 16:30 | 2026-06-25 | DFTX | Definium Therapeutics, Inc. | Wiley Matthew T. | Chief Commercial Off | S - Sale | $45.03 | -2,867 | 174.6K | -2% | -$129.1K |
| 2026-06-22 09:45 | 2026-06-22 | DFTX | Definium Therapeutics, Inc. | Wiley Matthew T. | Chief Commercial Off | A - Grant | $0.00 | +62.5K | 177.5K | +54% | $0 | |
| 2026-02-05 | 2026-02-03 | DFTX | Definium Therapeutics, Inc. | Wiley Matthew T. | Chief Commercial Off | A - Grant | $0.00 | +115.0K | 115.0K | New | $0 | |
| 2021-07-02 | 2021-06-30 | YARW | Yarrow Bioscience, Inc. | Wiley Matthew T. | Chief Commercial Off | F - Tax | $3.51 | -5,151 | 109.2K | -5% | -$18.1K |
Purchase Sale Sale after option exercise All abbreviations